Cargando…
MicroRNA-regulated, Systemically Delivered rAAV9: A Step Closer to CNS-restricted Transgene Expression
Recombinant adeno-associated viruses (rAAVs) that can cross the blood–brain-barrier and achieve efficient and stable transvascular gene transfer to the central nervous system (CNS) hold significant promise for treating CNS disorders. However, following intravascular delivery, these vectors also targ...
Autores principales: | Xie, Jun, Xie, Qing, Zhang, Hongwei, Ameres, Stefan L, Hung, Jui-Hung, Su, Qin, He, Ran, Mu, Xin, Seher Ahmed, Seemin, Park, Soyeon, Kato, Hiroki, Li, Chengjian, Mueller, Christian, Mello, Craig C, Weng, Zhiping, Flotte, Terence R, Zamore, Phillip D, Gao, Guangping |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3048189/ https://www.ncbi.nlm.nih.gov/pubmed/21179009 http://dx.doi.org/10.1038/mt.2010.279 |
Ejemplares similares
-
Long-term, efficient inhibition of microRNA function in mice using rAAV vectors
por: Xie, Jun, et al.
Publicado: (2012) -
Liver targeting with rAAV7: balancing tropism with immune profiles
por: Flotte, Terence R.
Publicado: (2021) -
rAAV-delivered PTEN therapeutics for prostate cancer
por: Ai, Jianzhong, et al.
Publicado: (2021) -
The AAV capsid can influence the epigenetic marking of rAAV delivered episomal genomes in a species dependent manner
por: Gonzalez-Sandoval, Adriana, et al.
Publicado: (2023) -
Durability of transgene expression after rAAV gene therapy
por: Muhuri, Manish, et al.
Publicado: (2022)